PWM
MIRM icon

Palumbo Wealth Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Palumbo Wealth Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Sell
2,686
-2,300
-46% -$231K 0.07% 183
2026
Q1 		$461K Sell
4,986
-96
-2% -$9.03K 0.11% 131
2025
Q4 		$401K Buy
5,082
+840
+20% +$60.3K 0.1% 144
2025
Q3 		$311K Sell
4,242
-1,362
-24% -$86.6K 0.1% 130
2025
Q2 		$285K Buy
5,604
+228
+4% +$10.2K 0.09% 147
2025
Q1 		$242K Buy
+5,376
New +$253K 0.08% 153

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Palumbo Wealth Management's MIRM Position: Q2 2026 in Review

Palumbo Wealth Management reduced its Mirum Pharmaceuticals (MIRM) stake by 46% in Q2 2026, selling an estimated $231K and leaving 2,686 shares worth $314K. The position accounts for 0.07% of the portfolio, ranked #183.

Palumbo Wealth Management first reported a position in MIRM in Q1 2025 and has held it in 6 quarters since. The position peaked at $461K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Palumbo Wealth Management held 2,686 shares of Mirum Pharmaceuticals worth $314K as of Q2 2026.
  • Palumbo Wealth Management sold 2,300 Mirum Pharmaceuticals shares in Q2 2026, an estimated $231K.
  • Mirum Pharmaceuticals made up 0.07% of Palumbo Wealth Management's portfolio in Q2 2026, its #183 holding.
  • Palumbo Wealth Management first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Palumbo Wealth Management's Mirum Pharmaceuticals position peaked at $461K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.